US Executive Officer Management Changes SEC — September 03, 2026

USA Executive & Director Changes

By Gunpowder Editorial ·

30 high priority 30 total filings analysed

Executive Summary

The September 3, 2026, executive and director change filings reveal a period of significant leadership transition across US equities, with 30 filings covering CEO, CFO, and board-level changes. A key theme is orderly CFO succession planning, with companies like T-Mobile, WD-40, MediaAlpha, and CarGurus executing well-defined transitions, often promoting internal candidates or bringing back former executives, signaling stability.

However, several filings carry higher materiality due to concurrent financial performance disclosures, such as Guidewire Software's mixed FY2026 results (revenue up 23% YoY but license revenue down 18% QoQ) and UiPath's Q2 FY2027 beat (revenue up 13% YoY) with modest net new ARR of $37M. A notable risk flag is Netcapital Inc., where a director resigned citing an SEC civil action, representing a governance crisis. Positive signals include Vaxcyte's narrowed guidance for Phase 3 data (end of October 2026) and MediaAlpha's raised Q3 2026 guidance, both suggesting strong operational momentum. The filings also highlight a trend of leveraging experienced executives from larger firms (e.g., Byrna Technologies appointing a former Axon board member, Radiant Logistics hiring a former DB Schenker COO) to drive growth. Overall, the digest identifies actionable opportunities in companies with strong guidance and orderly transitions, while flagging governance and financial risks in others.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from September 02, 2026.

Investment Signals (12)

  • FY2026 total revenue grew 23% YoY to $1,475.4M, ARR up 19% to $1,242M, and GAAP EPS doubled to $1.63 from $0.81, but Q4 license revenue declined 18% QoQ and GAAP net income fell 40% due to a $24M FX loss [BULLISH/BEARISH]

  • Q2 FY2027 revenue of $410M beat estimates (+13% YoY), with GAAP operating income of $32M, but net new ARR of only $37M and dollar-based net retention of 109% indicate slowing expansion [BULLISH/BEARISH]

  • Raised Q3 2026 guidance to at or above top end of prior ranges, signaling strong near-term performance, while CFO transition is orderly with former CFO returning

  • Vaxcyte (BULLISH)

    Narrowed guidance for VAX-31 Phase 3 data to end of October 2026 (from Q4 2026), with new CMO from Pfizer (led Prevnar 13/20) and new CLO from Eli Lilly, strengthening leadership ahead of BLA submission

  • CFO transition with Jessica Uhl (former Shell CFO) appointed as CFO Designate, reaffirmed 2026 guidance and capital return program, signaling financial stability

  • Appointed Matthew McBrady, Ph.D., a former Axon board member (2001-2026), to its board, bringing deep expertise from Axon's growth to >$50B market cap, potentially accelerating Byrna's growth trajectory

  • Appointed David Buss as COO, who previously improved DB Schenker's North America operating margin by over 200% in five years, signaling potential operational improvements

  • Appointed Richard Fabian (ex-CEO of FUJIFILM Sonosite) as President, while retaining CTO Mathieu Burtnyk (inventor of TULSA-PRO algorithm), balancing execution and innovation

  • Director resigned citing SEC civil action filed on August 10, 2026, indicating serious governance and legal risks

  • Appointed Joseph Miller as CFO, who led Aurinia's commercial launch of LUPKYNIS, as company approaches pivotal NOVA-2 trial results for LB-102 in schizophrenia, a binary catalyst

  • CFO resigned for personal reasons, but interim CFO George Papanier has 40+ years of gaming experience and previously served as interim CFO in 2023, providing continuity

  • CFO resigned, but interim CFO Jessica Block (Chief AI Officer) brings 20+ years of experience and will advance AI strategy, potentially driving new growth

Risk Flags (10)

  • Director Avi Liss resigned citing an SEC civil action (filed Aug 10, 2026), indicating potential fraud or regulatory violations; new director Cesar Herrera has no public company board experience

  • License revenue declined 18% QoQ and 7% YoY, while GAAP net income fell 40% in Q4 due to a $24M FX loss, signaling potential core product headwinds

  • UiPath/Slowing Growth [MODERATE RISK]

    Net new ARR of only $37M in Q2 FY2027 and dollar-based net retention of 109% (down from historical levels) suggest decelerating customer expansion and potential market saturation

  • EVP & Chief Strategy Officer departing with no successor or interim arrangement announced, creating a leadership gap in strategy function

  • VP, Corporate Controller and CAO retiring March 2027, creating a transition risk for financial reporting and internal controls

  • Controller and CAO retiring March 2027, with successor appointed, but transition period of one year could lead to temporary inefficiencies

  • CFO resigned with only an interim CFO appointed, and the search for a permanent successor creates uncertainty around financial leadership

  • Chief Accounting Officer resigned with no successor named; CFO assuming duties adds to his workload and may strain financial reporting

  • CFO resigned with a separation agreement including a six-month advisory period, but no permanent successor announced, creating financial leadership uncertainty

  • Director resigned effective immediately with no reason given and no successor named, suggesting potential undisclosed issues

Opportunities (10)

  • Narrowed guidance for Phase 3 OPUS-1 data to end of October 2026, with 6,191 adults dosed; positive data could trigger significant upside as company is pre-revenue with no approved products

  • Raised Q3 2026 guidance to at or above top end, with CFO transition bringing back former CFO Tigran Sinanyan who knows the business well; company generated 141M consumer referrals in 2025

  • New board member Matthew McBrady brings 25 years of experience from Axon's growth to >$50B market cap, potentially providing strategic insights for Byrna's next growth phase

  • New COO David Buss previously improved DB Schenker's North America operating margin by over 200% in five years, suggesting potential for similar margin expansion at Radiant

  • New CFO Joseph Miller brings commercial launch experience from Aurinia, as company approaches NOVA-2 trial results for LB-102 in schizophrenia; positive data could lead to significant value creation

  • Appointment of Jessica Uhl (former Shell CFO) as CFO Designate, with reaffirmed 2026 guidance and capital return program, provides visibility and stability for investors

  • New President Richard Fabian brings commercial expertise from FUJIFILM Sonosite, while CTO Mathieu Burtnyk continues to lead innovation, potentially accelerating TULSA-PRO adoption

  • Keith Stauffer (ex-Galderma CFO) hired as VP Global Finance, becoming CFO in November 2026, with current CFO Sara Hyzer transitioning to Division President, ensuring smooth handoff and continuity

  • Matthew Mandel (Harvard MBA, ex-Wayfair) appointed as CFO effective Oct 19, 2026, bringing e-commerce and private equity experience to drive financial strategy

  • Shareholders approved issuance of shares exceeding 20% of outstanding and increased equity incentive plan by 20M shares, providing capital for growth initiatives

Sector Themes (5)

  • Orderly CFO Succession Across Multiple Sectors

    6 companies (T-Mobile, WD-40, MediaAlpha, CarGurus, Bunge Global, Resources Connection) announced planned CFO transitions with clear timelines and successors, indicating a trend of proactive leadership planning to minimize disruption

  • Leveraging Big-Company Talent for Growth

    Several companies (Byrna Technologies, Radiant Logistics, Profound Medical, Vaxcyte) appointed executives from much larger firms (Axon, DB Schenker, FUJIFILM, Pfizer) to drive growth, suggesting a strategy to import proven leadership and best practices

  • Mixed Financial Performance Amid Leadership Changes

    Companies with concurrent financial disclosures showed divergent results: Guidewire (revenue +23% YoY but license revenue -18% QoQ) and UiPath (revenue +13% YoY but slowing net new ARR) highlight the importance of evaluating leadership changes in context of underlying business trends

  • Governance Risks in Small-Cap Companies

    Netcapital Inc.'s director resignation due to SEC civil action and GrabAGun Digital's CFO departure with no permanent successor underscore elevated governance and leadership risks in smaller, less-established companies

  • Clinical-Stage Biotech Leadership Strengthening

    Vaxcyte and LB Pharmaceuticals both appointed experienced executives (from Pfizer, Eli Lilly, Aurinia) ahead of pivotal clinical data readouts, indicating a pattern of bolstering management teams to maximize chances of successful commercialization

Watch List (8)

  • Topline data expected end of October 2026; positive results could be a major catalyst for this pre-revenue biotech

  • Company raised guidance to at or above top end; watch for actual results and any further guidance changes in upcoming earnings release

  • SEC civil action filed August 10, 2026; monitor for developments, potential fines, or delisting risks

  • Company provided ARR guidance of $1,450M-$1,460M and revenue of $1,707M-$1,727M; watch for execution against these targets in upcoming quarters

  • Watch for net new ARR trends and dollar-based net retention rate; any acceleration would be positive, while further deceleration would be concerning

  • Jessica Uhl becomes CFO Designate in mid-September 2026, with full CFO role in February 2027; monitor for any strategic changes under new financial leadership

  • Pivotal Phase 2/3 results for LB-102 in schizophrenia; binary catalyst that could significantly impact stock price

  • Ragnar Udd becomes CEO on February 1, 2027; watch for any strategic shifts in the lithium market strategy

Filing Analyses (30)
RADIANT LOGISTICS, INC 8-K neutral materiality 5/10

03-09-2026

Radiant Logistics appointed David Buss as Senior Vice President and COO, effective August 31, 2026. Mr. Buss brings over 30 years of logistics experience, including a prior role as CEO of DB Schenker's North America Cluster where he improved operating margin by over 200% in five years. The company also announced its 2026 Annual Meeting will be held on November 16, 2026, with record and proposal deadlines in September.

  • · Mr. Buss served as an independent private equity transportation logistics advisor from August 2025 to July 2026.
  • · He was promoted to the North America Cluster leadership role at DB Schenker in April 2023 and served on the integration steering committee for the USA Truck acquisition until July 2025.
  • · The employment agreement provides six months severance for termination due to death/disability or without cause, and twelve months severance if termination occurs within nine months after a Change of Control.
  • · Stockholder proposals for the 2026 Annual Meeting must be received by September 27, 2026; director nominations by September 17, 2026.
  • · The record date for voting at the Annual Meeting is September 29, 2026.
Profound Medical Corp. 8-K positive materiality 5/10

03-09-2026

Profound Medical Corp. appointed Richard Fabian as President, effective immediately, succeeding Mathieu Burtnyk who becomes Chief Technology Officer. Fabian brings over 29 years of healthcare industry experience, most recently as CEO of FUJIFILM Sonosite, and previously in senior roles at Philips Healthcare. The leadership change aims to sharpen execution while retaining Burtnyk to lead clinical innovation.

  • · Richard Fabian holds a Bachelor of Economics from the University of Michigan and an MBA from the University of Pittsburgh Joseph M. Katz Graduate School of Business.
  • · Mathieu Burtnyk is the inventor of the patented closed-loop temperature feedback control algorithm used by TULSA-PRO®.
  • · Profound Medical's technologies are approved across major global markets including FDA clearance for TULSA-PRO in the US and Sonalleve HDE for osteoid osteomas.
Byrna Technologies Inc. 8-K positive materiality 5/10

03-09-2026

Byrna Technologies appointed Matthew McBrady, Ph.D., a former long-time board member of Axon Enterprise (market cap >$50B), to its Board of Directors, increasing board size from seven to eight as part of a planned refreshment strategy. Dr. McBrady brings deep experience from Axon's growth journey, capital markets expertise as a former hedge fund and private equity investor, and currently serves as CFO of GoBrands (GoPuff). The appointment is expected to provide valuable insights for Byrna's next growth phase, though no specific financial metrics or performance data were disclosed in this filing.

  • · Dr. McBrady served on Axon's board from 2001 to 2014 and again from 2016 to 2026, chairing Audit, Compensation, and M&A & Capital Structure Committees.
  • · He currently serves as CFO of GoBrands (GoPuff) since 2025 and previously spent five years as Professor of Practice in Finance at Darden School.
  • · Earlier career includes roles as Managing Director and CIO of Multi-Strategy Hedge Funds at BlackRock, and Senior Associate at Bain Capital.
  • · He served as an international economist for President Clinton's Council of Economic Advisers and the U.S. Treasury from 1998 to 2000.
  • · Dr. McBrady holds a B.A. in Economics from Harvard, an M.Sc. from Oxford (Marshall Scholar), and a Ph.D. in Business Economics from Harvard.
SCOTTS MIRACLE-GRO CO 8-K neutral materiality 4/10

03-09-2026

The Scotts Miracle-Gro Company announced the departure of Christopher J. Hagedorn, Executive Vice President & Chief Strategy Officer, effective September 30, 2026. The separation was mutually agreed upon on August 29, 2026. No financial details or replacement plans were disclosed.

  • · Departure effective date: September 30, 2026
  • · Agreement date: August 29, 2026
  • · No successor or interim arrangement mentioned
Guidewire Software, Inc. 8-K mixed materiality 8/10

03-09-2026

Guidewire Software reported strong fiscal year 2026 results with total revenue up 23% to $1,475.4M and ARR growing 19% to $1,242M. However, license revenue declined 7% for the full year and 18% in Q4, while GAAP net income in Q4 fell to $31.4M from $52.0M a year ago due to a $24.0M foreign currency loss. The company provided fiscal 2027 guidance for ARR of $1,450M-$1,460M and total revenue of $1,707M-$1,727M.

  • · GAAP diluted net income per share for FY 2026 was $1.63, up from $0.81 in FY 2025.
  • · Non-GAAP diluted net income per share for FY 2026 was $3.43, up from $2.51 in FY 2025.
  • · Cash, cash equivalents, and investments decreased to $1,215.3M from $1,483.2M at year-end FY 2025, partly due to $606.3M in share repurchases.
  • · The company repurchased 4,085,350 shares at an average price of $148.41 during FY 2026.
  • · GAAP net income in Q4 FY 2026 was negatively impacted by a $24.0M foreign currency loss, compared to a $2.8M gain in Q4 FY 2025.
  • · Fiscal year 2027 guidance includes ending ARR of $1,450M-$1,460M and total revenue of $1,707M-$1,727M.
  • · The company has over 570 insurers in 44 countries and has completed 1700+ implementation projects.
CF Industries Holdings, Inc. 8-K neutral materiality 2/10

03-09-2026

CF Industries Holdings, Inc. disclosed that Vice President, Corporate Controller, and Chief Accounting Officer Richard A. Hoker intends to retire effective March 3, 2027. The filing provides no financial data or performance metrics, only a routine officer departure announcement.

NETSTREIT Corp. 8-K neutral materiality 3/10

03-09-2026

NETSTREIT Corp. announced the mutual departure of Sofia Chernylo as Senior Vice President and Chief Accounting Officer, effective September 1, 2026, with no disagreement over accounting matters. Matthew Fennewald, age 36, was appointed as her successor, bringing internal experience as Vice President, Corporate Controller since February 2024 and prior roles at PricewaterhouseCoopers and Crowe Horwath. The transition appears orderly and routine, with no new material plans or arrangements disclosed.

  • · Matthew Fennewald joined NETSTREIT in August 2020 and has served as Vice President, Corporate Controller since February 2024.
  • · Prior roles at NETSTREIT include Director, Corporate Controller (March 2023–February 2024), Corporate Controller (March 2022–February 2023), and Financial Reporting Manager (August 2020–February 2022).
  • · Before NETSTREIT, Fennewald worked at PricewaterhouseCoopers LLP (2015–2020) and Crowe Horwath LLP (2012–2015).
  • · Fennewald holds a Master of Science in Auditing and Financial Accounting from the University of North Texas and is a licensed CPA.
  • · No family relationships or reportable transactions exist between Fennewald and the company's directors or executive officers.
RESOURCES CONNECTION, INC. 8-K neutral materiality 5/10

03-09-2026

Resources Connection, Inc. (RGP) announced the resignation of CFO Jennifer Y. Ryu, effective October 2, 2026, and the appointment of Jessica Block as interim CFO. Ms. Block, who joined RGP in March 2026 as Chief AI Officer, brings over 20 years of experience in professional services, including a prior interim CFO role at Factor. The company will initiate a search for a permanent successor, while Ms. Block's appointment aims to ensure continuity and continued focus on strategic priorities, including advancing RGP's AI strategy.

  • · RGP has served 90% of the Fortune 100 as of May 2026.
  • · RGP has been recognized by U.S. News & World Report (2025-2026 Best Companies to Work for) and Forbes (America’s Best Midsize Employers 2026, America’s Best Management Consulting Firms 2025, World’s Best Management Consulting Firms 2025).
  • · RGP is listed on the Nasdaq Global Select Market, the exchange’s highest tier by listing standards.
James River Group Holdings, Inc. 8-K neutral materiality 2/10

03-09-2026

On September 3, 2026, James River Group Holdings, Inc. (JRVR) disclosed in an 8-K filing that director Thomas L. Brown will not seek re-election at the 2026 annual general meeting, effective August 31, 2026. The departure is not due to any disagreement with the company's operations, policies, or practices. The filing does not include any financial data or forward-looking guidance.

  • · Mr. Brown's decision was not due to any disagreement with the company.
  • · The departure relates to the 2026 annual general meeting of shareholders.
Bunge Global SA 8-K neutral materiality 3/10

03-09-2026

Bunge Global SA announced the planned retirement of Controller and CAO Matt Simmons effective March 31, 2027, with Richard James succeeding him on April 1, 2027. The transition is orderly and not due to any disagreement. Mr. James brings over 14 years of experience at Bunge and multiple professional certifications.

  • · Matt Simmons will retire as Controller and CAO effective March 31, 2027, and will remain through the transition period.
  • · Richard James, age 45, has served as Vice President, Finance Integration and Transformation since December 2022.
  • · Richard James holds a Bachelor of Science in Biology from the University of London (2002) and an MBA from Columbia Business School (2012).
  • · Richard James is a CPA, Chartered Professional Accountant (Canada), Chartered Accountant (England & Wales), and Certified Internal Auditor.
Vaxcyte, Inc. 8-K positive materiality 7/10

03-09-2026

Vaxcyte appointed Luis Jodar, Ph.D. as Chief Medical Officer and David McAvoy, J.D. as Chief Legal Officer, strengthening its leadership ahead of a key clinical milestone. The company also narrowed its guidance for topline data from the VAX-31 adult Phase 3 OPUS-1 trial to end of October 2026, from the prior Q4 2026 range. The appointments and data timeline signal progress toward a planned BLA submission and potential commercialization, though the company remains a clinical-stage entity with no approved products.

  • · Luis Jodar spent 17 years at Pfizer, most recently as SVP and CMO for Vaccines and Infectious Diseases, and led clinical/regulatory work for Prevnar 13 and Prevnar 20.
  • · David McAvoy spent 27 years at Eli Lilly in senior legal roles and was General Counsel of Endocyte through its $2.1B acquisition by Novartis.
  • · The OPUS program includes three fully enrolled trials with 6,191 adults dosed total; ~3,500 received VAX-31.
  • · OPUS-2 and OPUS-3 topline data expected in first half of 2027.
  • · VAX-31 is the broadest-spectrum PCV candidate in the clinic today (31-valent).
  • · VAX-24 has positive Phase 2 results in adults and infants.
  • · VAX-A1 (Group A Strep) is in Phase 1.
  • · VAX-GI (Shigella) is in pipeline.
  • · XpressCF platform is exclusively licensed from Sutro Biopharma.
RALPH LAUREN CORP 8-K neutral materiality 4/10

03-09-2026

Ralph Lauren Corporation announced expanded roles for key enterprise leaders effective November 29, 2026, following the retirement of COO Bob Ranftl. Halide Alagöz becomes Chief Operating & Product Officer, adding AI strategy and architecture & design to her product and merchandising responsibilities; CFO Justin Picicci adds real estate and logistics; CMO Iris Langlois-Meurinne adds licensing; and Katie Ioanilli adds the Design with Intent initiative. The changes support the Next Great Chapter: Drive strategy, but no financial metrics or performance data were disclosed.

  • · Halide Alagöz will assume leadership of AI strategy and architecture & design organization.
  • · Justin Picicci will add global responsibility for real estate and logistics.
  • · Iris Langlois-Meurinne will take on leadership of Ralph Lauren’s licensing business.
  • · Katie Ioanilli will expand her role to include Design with Intent, an industry-leading cultural collaboration initiative.
  • · Bob Ranftl's retirement is effective November 29, 2026.
T-Mobile US, Inc. 8-K positive materiality 6/10

03-09-2026

T-Mobile US announced the planned retirement of CFO Peter Osvaldik in July 2027 and the appointment of Jessica Uhl as CFO Designate, effective mid-September 2026, to succeed him in February 2027. Uhl brings extensive financial leadership from Shell and GE Vernova. The company reaffirmed its 2026 financial guidance and capital return program.

  • · Peter Osvaldik joined T-Mobile in 2016 and has served as CFO since 2020.
  • · Osvaldik's one-year contract extension was previously made to support the CEO transition.
  • · Jessica Uhl has a 30-year career, was CFO of Shell, and most recently President of GE Vernova.
  • · The transition includes an extended transition period and a Strategic Advisor role for Osvaldik until his planned retirement on July 1, 2027.
BNB PLUS CORP. 8-K neutral materiality 6/10

03-09-2026

BNB Plus Corp. announced the resignation of three directors (Robert B. Catell, Joseph D. Ceccoli, Dr. Yacov Shamash) effective September 3, 2026, with no disagreement cited, and appointed three new directors (Richard Shorten, Todd Larsen, Lok Lee) to fill the vacancies. The new directors bring ties to blockchain/AI infrastructure and a strategic advisory engagement with GlobalStake, which is affiliated with a major shareholder (Comstock). The company has paid a $300,000 pre-paid advisory fee for a four-month strategic review, and recent private placements with Comstock GP generated gross proceeds of $5.0 million and $747.8 thousand.

  • · New directors Larsen and Lee will serve on Audit and Compensation Committees; Larsen also on Nominating Committee.
  • · Compensation for new directors to be agreed upon at a later date.
  • · GlobalStake strategic review will cover business, assets, and capital structure over an initial four-month term.
  • · Comstock GP is a current shareholder and participant in both the October 2025 PIPE and May 2026 private placement.
  • · No disagreements were cited for the resignations.
Frontdoor, Inc. 8-K neutral materiality 3/10

03-09-2026

Frontdoor, Inc. announced the resignation of Sally J. Shanks, Vice President, Chief Accounting Officer and Controller, effective September 18, 2026, to pursue other business opportunities. Her departure is not due to any disagreement with the company. CFO Jason L. Bailey will assume principal accounting officer duties until a successor is appointed.

  • · Resignation effective date: September 18, 2026
  • · No disagreement with company, management, or board cited
  • · CFO Jason L. Bailey will serve as interim principal accounting officer
ESS Tech, Inc. 8-K neutral materiality 3/10

03-09-2026

ESS Tech, Inc. entered into employment agreements with CFO Kate Suhadolnik and CSO/GC Kelly F. Goodman on August 28, 2026, formalizing terms without any change in roles or responsibilities. Each executive receives a base salary of $380,000 and enhanced severance benefits tied to a change-in-control protective period, including 12 months' salary, COBRA premiums, and full equity acceleration. The agreements also include customary non-compete and non-solicitation covenants.

  • · Employment agreements were not entered into in connection with any change in title, role, or responsibilities.
  • · Annual cash incentive bonus eligibility terms remain unchanged from prior disclosures.
  • · Severance benefits apply only during the CIC Protective Period (one month before to 12 months after a Change in Control).
  • · Severance includes 12 months' base salary, 12 months of COBRA premiums, and full acceleration of unvested equity awards.
  • · Agreements contain customary confidentiality, non-solicitation, and non-competition covenants.
UiPath, Inc. 8-K mixed materiality 8/10

03-09-2026

UiPath reported Q2 FY2027 revenue of $410 million, up 13% YoY, and ARR of $1.938 billion, up 12% YoY, with GAAP operating income of $32 million and non-GAAP operating income of $89 million. The company announced leadership changes, including a new CFO and a new Board member, and provided Q3 and full-year guidance. However, net new ARR of $37 million was modest, and the dollar-based net retention rate of 109% indicates slowing expansion.

  • · Net new ARR of $37 million in Q2 FY2027.
  • · Dollar-based net retention rate of 109%.
  • · GAAP gross margin of 80% and non-GAAP gross margin of 82%.
  • · Leadership changes: Ashim Gupta to focus solely on COO role; Hitesh Ramani promoted to CFO; Brad Brubaker named Chief Legal & Administrative Officer.
  • · Yazdi Bagli appointed to the Board of Directors.
  • · Q3 FY2027 guidance: revenue $440M-$445M, ARR $1.992B-$1.997B, non-GAAP operating income ~$100M.
  • · Full year FY2027 guidance: revenue $1.789B-$1.794B, ARR $2.065B-$2.070B, non-GAAP operating income ~$445M.
  • · Cash position of $1.405 billion as of July 31, 2026.
Bally's Corp 8-K neutral materiality 6/10

03-09-2026

Bally's Corporation announced the resignation of EVP and CFO Mira Mircheva for personal reasons, effective September 4, 2026, with a transition period through September 30, 2026. The Board appointed President and Board member George Papanier as Interim CFO, effective September 4, 2026, leveraging his 40+ years of gaming industry experience and prior CFO role in 2023. The company has commenced a search for a permanent CFO, and management expressed confidence in continued operational and financial stability.

  • · Mira Mircheva's resignation is effective September 4, 2026, with a transition period through September 30, 2026.
  • · George Papanier previously served as interim CFO in 2023 and as CEO from February 2011 to October 2021.
  • · Bally's operates 20 casinos across 11 U.S. states and one in Newcastle, UK, with approximately 17,700 slot machines, 630 table games, and 3,950 hotel rooms.
  • · Bally's has over 12,000 employees globally and holds a majority interest in Bally's Intralot S.A.
GrabAGun Digital Holdings Inc. 8-K neutral materiality 3/10

03-09-2026

GrabAGun Digital Holdings Inc. (PEW-WT) announced the departure of CFO Justin Hilty, effective September 1, 2026, under a Separation Agreement. The agreement includes a six-month advisory period (minimum 40 hours/month) with an hourly cash fee, acceleration of 66,667 unvested RSUs, and standard restrictive covenants. No financial terms of the consulting fee or any severance payment were disclosed.

  • · Mr. Hilty resigned as CFO effective August 14, 2026, and retired effective September 1, 2026.
  • · Advisory period runs from September 1, 2026 through March 1, 2027.
  • · Mr. Hilty remains subject to restrictive covenants from a Non-Competition and Non-Solicitation Agreement dated January 6, 2025.
  • · The Separation Agreement includes a general release of claims through the Separation Date.
LiveWire Group, Inc. 8-K neutral materiality 3/10

03-09-2026

LiveWire Group, Inc. announced the resignation of Paul Krause from its Board of Directors effective August 31, 2026, and the appointment of Matt Ryan to the Board effective September 1, 2026. Mr. Ryan, who serves as Chief Marketing and Technology Officer of Harley-Davidson, Inc., will not receive additional compensation for his director role.

  • · Paul Krause resigned effective end of day August 31, 2026.
  • · Matt Ryan was appointed effective September 1, 2026.
  • · Mr. Ryan will not receive additional compensation for his board service due to his current role at Harley-Davidson, Inc.
Netcapital Inc. 8-K negative materiality 8/10

03-09-2026

Netcapital Inc. (NCPLW) disclosed the resignation of director Avi Liss on August 27, 2026, citing the SEC civil action filed against the company and certain individuals. The board elected Cesar Herrera as a new independent director on August 30, 2026, filling the vacancy and appointing him to the Audit and Compensation Committees. The filing reflects a board shake-up amid an SEC lawsuit, but no financial metrics or performance data are provided.

  • · The SEC civil action was filed on August 10, 2026, in the U.S. District Court for the District of Massachusetts (Case No. 1:26-cv-13665).
  • · Mr. Liss stated he did not know of, be involved in, participate in, or receive any financial benefit from the alleged conduct.
  • · Cesar Herrera has served as CEO and director of KRTL Holding Group Inc. since December 2021 and holds a California real estate broker license since 2006.
  • · The board determined all three directors are independent under Nasdaq rules.
  • · Mr. Herrera was not designated as an audit committee financial expert.
ALBEMARLE CORP 8-K neutral materiality 6/10

03-09-2026

Albemarle Corporation announced a CEO succession plan: Ragnar Udd will become President and CEO effective February 1, 2027, succeeding Kent Masters, who will transition to Executive Chairman. Udd brings over 25 years of experience from BHP, where he served as Chief Commercial Officer. The transition is designed to ensure leadership continuity, with Masters serving as Executive Chairman through the 2027 annual meeting.

  • · Udd will join the Albemarle Board of Directors upon becoming CEO.
  • · Masters will serve as Executive Chairman through the 2027 annual meeting, after which his role will be reviewed as part of the Board's annual director nomination process.
  • · Udd's experience includes roles as President Americas at BHP (leading copper and potash businesses), interim Chief Technology Officer, BHP Mitsubishi Asset President, and Vice President Logistics and Infrastructure for Western Australia Iron Ore.
LB PHARMACEUTICALS INC 8-K neutral materiality 5/10

03-09-2026

LB Pharmaceuticals appointed Joseph Miller as CFO, effective September 3, 2026. Miller brings over 20 years of biopharmaceutical finance experience, including leading Aurinia Pharmaceuticals through its commercial launch of LUPKYNIS. The company is approaching pivotal NOVA-2 clinical trial results for lead candidate LB-102 in schizophrenia, but remains pre-revenue with no approved products and faces significant development and regulatory risks.

  • · Joseph Miller previously served as CFO of Aurinia Pharmaceuticals, where he oversaw the commercial launch of LUPKYNIS, the first FDA-approved oral therapy for active lupus nephritis.
  • · Miller also served as CFO, Principal Executive Officer, and Corporate Secretary of Avalo Therapeutics, leading acquisitions of Aevi Genomic Medicine and Ichorion Therapeutics and the divestiture of Avalo's commercial portfolio to Aytu BioScience.
  • · Earlier roles include VP of Finance at Sucampo Pharmaceuticals (which merged with Mallinckrodt) and finance leadership at QIAGEN, Eppendorf, and KPMG LLP.
  • · Miller holds a B.S. in accounting from Villanova University and is a Certified Public Accountant.
  • · The company has no approved products and is pre-revenue, with all forward-looking statements subject to risks including limited operating history, historical losses, and dependence on LB-102.
Alaska Silver Corp. 8-K neutral materiality 3/10

03-09-2026

Alaska Silver Corp. granted 375,000 stock options to non-executive directors at C$0.71 per share for a five-year term, as part of its director compensation policy. The company also provided an update on its Illinois Creek Project in Alaska, which hosts significant silver, gold, zinc, and lead resources. No financial results or period-over-period comparisons were included in this filing.

  • · The Illinois Creek Project is located 38 km from the Yukon River, the region's primary marine transportation corridor.
  • · The Waterpump Creek zone remains open to the north and south.
  • · The Illinois Creek Mine was a past producer that closed in 1998 and was reclaimed in 2002 due to low metal prices.
  • · The company is headquartered in Alaska and Arizona.
CarGurus, Inc. 8-K neutral materiality 5/10

03-09-2026

CarGurus appointed Matthew Mandel as CFO, effective Oct. 19, 2026, succeeding CEO Jason Trevisan who served as interim CFO since March 2025. Mandel brings experience from Fleetio, Cometeer, Wayfair, and private equity firms. The filing contains no financial results or period-over-period comparisons.

  • · Mandel's start date is Oct. 19, 2026.
  • · He will report to CEO Jason Trevisan.
  • · Mandel holds an MBA from Harvard Business School and a BA from Duke University.
  • · He was CFO and COO at Fleetio since November 2023.
  • · Trevisan had served as interim principal financial and principal accounting officer since March 2025.
MediaAlpha, Inc. 8-K positive materiality 7/10

03-09-2026

MediaAlpha announced that Pat Thompson will step down as CFO effective October 1, 2026, with Tigran Sinanyan (SVP of Finance and former CFO from 2015-2021) succeeding him. The company also raised its Q3 2026 guidance, now expecting Revenue, Contribution, and Adjusted EBITDA at or above the top end of previously disclosed ranges. The transition is orderly, with Thompson remaining as consultant through February 2027, and the guidance upgrade signals strong near-term performance.

  • · Pat Thompson's last day as CFO is October 1, 2026; his last day with the company is October 30, 2026, followed by a consulting role through February 2027.
  • · Tigran Sinanyan previously served as MediaAlpha's CFO from 2015 to 2021 and as VP of Finance from 2012 to 2015, and rejoined as SVP of Finance in July 2025.
  • · The company generated over 141 million Consumer Referrals in 2025 and powered $2.2 billion in programmatic advertising spend.
  • · MediaAlpha has more than 1,150 active partners.
Trailblazer Holdings, Inc. 8-K positive materiality 7/10

03-09-2026

Cyabra, Inc. (formerly Trailblazer Holdings, Inc.) held a Special Meeting of Stockholders on September 2, 2026, where shareholders approved two proposals: the issuance of shares in connection with a Private Placement, Exchange Agreement, and Conversion Agreements (exceeding 20% of outstanding common stock), and an amendment to the 2026 Omnibus Equity Incentive Plan increasing the share reserve by 20,000,000 shares. The Plan Amendment also introduces an annual increase in the share reserve to 15% of fully diluted capitalization. Both proposals passed with strong majority support, though the Plan Amendment saw a notable minority of votes against it.

  • · The Plan Amendment was previously approved by the Board of Directors on July 31, 2026, subject to stockholder approval.
  • · The Company is an emerging growth company and has not elected to use the extended transition period for new financial accounting standards.
  • · The Company's common stock trades on The Nasdaq Stock Market LLC under the symbol CYAB.
  • · The Company's principal executive office is located at 13 Gershon Shatz, Tel Aviv, Israel.
Federal Home Loan Bank of Des Moines 8-K neutral materiality 3/10

03-09-2026

Federal Home Loan Bank of Des Moines announced the appointment of Wil W. Osborn as President and CEO, effective October 1, 2026, succeeding Kristina K. Williams who is retiring after serving since January 2020. Osborn, currently the Bank's Chief Business Officer and a former CFO of FHLB Topeka, was selected through a comprehensive succession planning process led by the board. The transition represents a leadership change at a key government-sponsored enterprise with over 1,200 member institutions.

  • · Transition effective date: October 1, 2026
  • · Williams announced retirement in January 2026
  • · Board engaged an executive search firm for the process
  • · Osborn served as CFO of Federal Home Loan Bank of Topeka from 2010 before joining FHLB Des Moines in 2020
  • · FHLB Des Moines serves 13 states and 3 U.S. Pacific territories
  • · Bank is wholly owned by its members and receives no taxpayer funding
OLD DOMINION ELECTRIC COOPERATIVE 8-K neutral materiality 2/10

03-09-2026

On September 1, 2026, Paul H. Brown notified Old Dominion Electric Cooperative of his resignation from the board of directors, effective immediately. The filing does not provide a reason for the departure or name a successor. No financial impact or other operational changes were disclosed.

  • · Resignation effective September 1, 2026, the same day as the notification.
  • · No successor or interim replacement has been announced.
  • · The filing does not disclose any disagreement between Mr. Brown and the company.
WD 40 CO 8-K neutral materiality 4/10

03-09-2026

WD-40 Company announced the hiring of Keith Stauffer as Vice President, Global Finance, effective September 7, 2026, who will become Chief Financial Officer on November 2, 2026. Current CFO Sara Hyzer will transition to Division President, Americas on that same date, continuing in the CFO role through the filing of the fiscal year 2026 10-K. The leadership change follows a planned succession and aims to ensure a smooth handoff.

  • · Prior to WD-40, Mr. Stauffer served as CFO, U.S. at Galderma S.A. and as CFO of TerrAscend Corp. from 2020 to 2025.
  • · He holds a Bachelor of Science in Industrial Engineering and an MBA from Purdue University.
  • · Ms. Hyzer will remain CFO during the transition and through the filing of the fiscal year 2026 10-K.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 30 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Executive Officer Management Changes SEC

🇺🇸 More from United States

View all →